A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

Hepatology ◽  
2009 ◽  
Vol 50 (3) ◽  
pp. 717-726 ◽  
Author(s):  
Yves Benhamou ◽  
Nezam H. Afdhal ◽  
David R. Nelson ◽  
Mitchell L. Shiffman ◽  
Deanine G. Halliman ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Iii ◽  
Safety And Efficacy ◽  
Treatment Naïve ◽  
Phase Iii Study

scholarly journals Phase III results of Boceprevir in treatment naïve patients with chronic hepatitis C genotype 1

2011 ◽  
Vol 32 ◽  
pp. 27-31 ◽  
Author(s):  
Michael P. Manns ◽  
Antoaneta A. Markova ◽  
Beatriz Calle Serrano ◽  
Markus Cornberg
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Iii ◽  
Genotype 1 ◽  
Treatment Naïve

Daclatasvir and sofosbuvir with ribavirin for 24 weeks in chronic hepatitis C genotype-3-infected patients with cirrhosis: a Phase III study (ALLY-3C)

2018 ◽  
Vol 24 (1) ◽  
pp. 35-44 ◽  
Author(s):  
Fred Poordad ◽  
◽  
Mitchell L Shiffman ◽  
Wayne Ghesquiere ◽  
Alexander Wong ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Iii ◽  
Genotype 3 ◽  
Phase Iii Study

PTH-137 Safety and efficacy of simeprevir (SMV) plus PEG-IFN/RBV in treatment-naÏve chronic hepatitis c genotype 1 patients eligible for 12 weeks of treatment

Gut ◽  
2015 ◽  
Vol 64 (Suppl 1) ◽  
pp. A468.2-A469
Author(s):  
GR Foster ◽  
T Asselah ◽  
C Moreno ◽  
C Sarrazin ◽  
M Gschwantler ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Genotype 1 ◽  
Safety And Efficacy ◽  
Treatment Naïve

Response, relapse, re-treatment and viraemia in patients with chronic hepatitis C treated with alpha 2b interferon. A phase III study

1991 ◽  
Vol 13 ◽  
pp. S77
Author(s):  
G. Varagona ◽  
D. Brown ◽  
H. Kibler ◽  
P.J. Scheuer ◽  
P. Ashrafzadeh ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Phase Iii ◽  
Phase Iii Study

Impact of IL28B-genotype on virological response in treatment-naive Austrian patients with chronic hepatitis C

2010 ◽  
Vol 48 (05) ◽  
Author(s):  
A Staettermayer ◽  
K Rutter ◽  
S Beinhardt ◽  
TM Scherzer ◽  
K Zinober ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Virological Response ◽  
Il28b Genotype ◽  
Treatment Naïve
Sign in / Sign up

Export Citation Format

Share Document